30

Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 2: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 3: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 4: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 5: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 6: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 7: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 8: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 9: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 10: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 11: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 12: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 13: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 14: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 15: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 16: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 17: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 18: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 19: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 20: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 21: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 22: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 23: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 24: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 25: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 26: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 27: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 28: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 29: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded
Page 30: Home - ClinicalTrials.gov · 2019. 6. 20. · potential Day I MCSI 10 patients. After patient reaches week 12 (Visit 7), Dayl treatment received by the patient will be un-blinded